Toward a systems-level understanding of the Hedgehog signaling pathway: Defining the complex, robust, and fragile

Wiley Interdisciplinary Reviews: Systems Biology and Medicine

Volumn 5, Issue 1, 2013, Pages 83-100

  Tran, Pamela V ^a   Lachke, Salil A ^b   Stottmann, Rolf W ^c  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMS 833923; CURCUMIN; CYCLOPAMINE; EPIGALLOCATECHIN GALLATE; GANT 58; GANT 61; GENISTEIN; IPI 269609; ITRACONAZOLE; KETOCONAZOLE; LEQ 506; LY 2940680; MK 5710; MRT 83; MS 0022; N (3 METHOXYBENZYL) 3,3 DIMETHYL N [1 (3,4 METHYLENEDIOXYBENZYL) 2 (1 PIPERAZINYLCARBONYL) 4 PYRROLIDINYL]BUTYRAMIDE; NORVERAMILINE; PF 04449913; PF 5274857; PHYSALIN F; RESVERATROL; SARIDEGIB; SEN 450; SIMVASTATIN; SONIC HEDGEHOG PROTEIN; SONIDEGIB; STAUROSPORINE; TAK 441; TRIPARANOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VISMODEGIB; ZARAGOZIC ACID A; ZERUMBONE;

ADVANCED CANCER; ARTICLE; BASAL CELL CARCINOMA; BREAST CANCER; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL FATE; CELL ORGANELLE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM TUMOR; CHONDROSARCOMA; COLORECTAL CANCER; DRUG MECHANISM; ESOPHAGEAL ADENOCARCINOMA; FEEDBACK SYSTEM; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HOMEOSTASIS; HUMAN; LUNG SMALL CELL CANCER; MAMMAL; MEDULLOBLASTOMA; MOLECULAR DYNAMICS; MYELOFIBROSIS; NEGATIVE FEEDBACK; NONHUMAN; OVARY CANCER; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); POSITIVE FEEDBACK; RECURRENT CANCER; REGULATORY MECHANISM; SARCOMA; SIGNAL TRANSDUCTION; SOLID TUMOR; STOMACH ADENOCARCINOMA;

ANIMALS; DROSOPHILA; HEDGEHOG PROTEINS; HUMANS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

ERINACEIDAE;

EID: 84871388295     PISSN: 19395094     EISSN: 1939005X     Source Type: Journal    
DOI: 10.1002/wsbm.1193     Document Type: Article

References (146)

1. Rosslenbroich B. Outline of a concept for organismic systems biology. Semin Cancer Biol 2011, 21:156-164.
2. Kitano H. Systems biology: a brief overview. Science 2002, 295:1662-1664.
3. Antony PM, Balling R, Vlassis N. From systems biology to systems biomedicine. Curr Opin Biotechnol 2011, 23:604-608.
4. Costa J. Systems pathology: a critical review. Mol Oncol 2012, 6:27-32.
5. Kitano H. Towards a theory of biological robustness. Mol Syst Biol 2007, 3:137.
6. Nusslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in drosophila. Nature 1980, 287:795-801.
7. Kitano K. Scientific challenges in systems biology. Introduction to systems biology. Totawa, NJ: Humana Press; 2007, 3-13.
8. Dessaud E, McMahon AP, Briscoe J. Pattern formation in the vertebrate neural tube: a sonic hedgehog morphogen-regulated transcriptional network. Development 2008, 135:2489-2503.
9. Ingham PW, Nakano Y, Seger C. Mechanisms and functions of hedgehog signalling across the metazoa. Nat Rev Genet 2011, 12:393-406.
10. Pan Y, Wang B. A novel protein-processing domain in gli2 and gli3 differentially blocks complete protein degradation by the proteasome. J Biol Chem 2007, 282:10846-10852.
11. Chen MH, Gao N, Kawakami T, Chuang PT. Mice deficient in the fused homolog do not exhibit phenotypes indicative of perturbed hedgehog signaling during embryonic development. Mol Cell Biol 2005, 25:7042-7053.
12. Cheung HO, Zhang X, Ribeiro A, Mo R, Makino S, Puviindran V, Law KK, Briscoe J, Hui CC. The kinesin protein kif7 is a critical regulator of gli transcription factors in mammalian hedgehog signaling. Sci Signal 2009, 2:ra29.
13. Liem KF Jr, He M, Ocbina PJ, Anderson KV. Mouse kif7/costal2 is a cilia-associated protein that regulates sonic hedgehog signaling. Proc Natl Acad Sci U S A 2009, 106:13377-13382.
14. Hsu SH, Zhang X, Yu C, Li ZJ, Wunder JS, Hui CC, Alman BA. Kif7 promotes hedgehog signaling in growth plate chondrocytes by restricting the inhibitory function of sufu. Development 2011, 138:3791-3801.
15. Eggenschwiler JT, Anderson KV. Cilia and developmental signaling. Ann Rev Cell Dev Biol 2007, 23:345-373.
16. Praetorius HA, Spring KR. A physiological view of the primary cilium. Ann Rev Physiol 2005, 67:515-529.
17. Saraga-Babic M, Vukojevic K, Bocina I, Drnasin K, Saraga M. Ciliogenesis in normal human kidney development and post-natal life. Pediatr Nephrol 2012, 27:55-63.
18. Huangfu D, Liu A, Rakeman AS, Murcia NS, Niswander L, Anderson KV. Hedgehog signalling in the mouse requires intraflagellar transport proteins. Nature 2003, 426:83-87.
19. Huangfu D, Anderson KV. Cilia and hedgehog responsiveness in the mouse. Proc Natl Acad Sci U S A 2005, 102:11325-11330.
20. Liu A, Wang B, Niswander LA. Mouse intraflagellar transport proteins regulate both the activator and repressor functions of gli transcription factors. Development 2005, 132:3103-3111.
21. May SR, Ashique AM, Karlen M, Wang B, Shen Y, Zarbalis K, Reiter J, Ericson J, Peterson AS. Loss of the retrograde motor for ift disrupts localization of smo to cilia and prevents the expression of both activator and repressor functions of gli. Dev Biol 2005, 287:378-389.
22. Tran PV, Haycraft CJ, Besschetnova TY, Turbe-Doan A, Stottmann RW, Herron BJ, Chesebro AL, Qiu H, Scherz PJ, Shah JV, et al. Thm1 negatively modulates mouse sonic hedgehog signal transduction and affects retrograde intraflagellar transport in cilia. Nat Genet 2008, 40:403-410.
23. Qin J, Lin Y, Norman RX, Ko HW, Eggenschwiler JT. Intraflagellar transport protein 122 antagonizes sonic hedgehog signaling and controls ciliary localization of pathway components. Proc Natl Acad Sci U S A 2011, 108:1456-1461.
24. Rohatgi R, Milenkovic L, Scott MP. Patched1 regulates hedgehog signaling at the primary cilium. Science 2007, 317:372-376.
25. Rohatgi R, Milenkovic L, Corcoran RB, Scott MP. Hedgehog signal transduction by smoothened: pharmacologic evidence for a 2-step activation process. Proc Natl Acad Sci U S A 2009, 106:3196-3201.
26. Kim J, Kato M, Beachy PA. Gli2 trafficking links hedgehog-dependent activation of smoothened in the primary cilium to transcriptional activation in the nucleus. Proc Natl Acad Sci U S A 2009, 106:21666-21671.
27. Humke EW, Dorn KV, Milenkovic L, Scott MP, Rohatgi R. The output of hedgehog signaling is controlled by the dynamic association between suppressor of fused and the gli proteins. Genes Dev 2010, 24:670-682.
28. Tukachinsky H, Lopez LV, Salic A. A mechanism for vertebrate hedgehog signaling: recruitment to cilia and dissociation of sufu-gli protein complexes. J Cell Biol 2010, 191:415-428.
29. Wen X, Lai CK, Evangelista M, Hongo JA, de Sauvage FJ, Scales SJ. Kinetics of hedgehog-dependent full-length gli3 accumulation in primary cilia and subsequent degradation. Mol Cell Biol 2010, 30:1910-1922.
30. Ocbina PJ, Eggenschwiler JT, Moskowitz I, Anderson KV. Complex interactions between genes controlling trafficking in primary cilia. Nat Genet 2011, 43:547-553.
31. Su Y, Ospina JK, Zhang J, Michelson AP, Schoen AM, Zhu AJ. Sequential phosphorylation of smoothened transduces graded hedgehog signaling. Sci Signal 2011, 4:ra43.
32. Milenkovic L, Scott MP, Rohatgi R. Lateral transport of smoothened from the plasma membrane to the membrane of the cilium. J Cell Biol 2009, 187:365-374.
33. Tuson M, He M, Anderson KV. Protein kinase a acts at the basal body of the primary cilium to prevent gli2 activation and ventralization of the mouse neural tube. Development 2011, 138:4921-4930.
34. Evangelista M, Lim TY, Lee J, Parker L, Ashique A, Peterson AS, Ye W, Davis DP, de Sauvage FJ. Kinome sirna screen identifies regulators of ciliogenesis and hedgehog signal transduction. Sci Signal 2008, 1:ra7.
35. Varjosalo M, Bjorklund M, Cheng F, Syvanen H, Kivioja T, Kilpinen S, Sun Z, Kallioniemi O, Stunnenberg HG, He WW, et al. Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling. Cell 2008, 133:537-548.
36. Mizuarai S, Kawagishi A, Kotani H. Inhibition of p70s6k2 down-regulates hedgehog/gli pathway in non-small cell lung cancer cell lines. Mol Cancer 2009, 8:44.
37. Citri A, Yarden Y. Egf-erbb signalling: towards the systems level. Nat Rev Mol Cell Biol 2006, 7:505-516.
38. Chuang PT, McMahon AP. Vertebrate hedgehog signalling modulated by induction of a hedgehog-binding protein. Nature 1999, 397:617-621.
39. Tenzen T, Allen BL, Cole F, Kang JS, Krauss RS, McMahon AP. The cell surface membrane proteins cdo and boc are components and targets of the hedgehog signaling pathway and feedback network in mice. Dev Cell 2006, 10:647-656.
40. Zhang XM, Ramalho-Santos M, McMahon AP. Smoothened mutants reveal redundant roles for shh and ihh signaling including regulation of l/r symmetry by the mouse node. Cell 2001, 106:781-792.
41. Zheng X, Mann RK, Sever N, Beachy PA. Genetic and biochemical definition of the hedgehog receptor. Genes Dev 2010, 24:57-71.
42. Allen BL, Song JY, Izzi L, Althaus IW, Kang JS, Charron F, Krauss RS, McMahon AP. Overlapping roles and collective requirement for the coreceptors gas1, cdo, and boc in shh pathway function. Dev Cell 2011, 20:775-787.
43. Bai CB, Stephen D, Joyner AL. All mouse ventral spinal cord patterning by hedgehog is gli dependent and involves an activator function of gli3. Dev Cell 2004, 6:103-115.
44. Park HL, Bai C, Platt KA, Matise MP, Beeghly A, Hui CC, Nakashima M, Joyner AL. Mouse gli1 mutants are viable but have defects in shh signaling in combination with a gli2 mutation. Development 2000, 127:1593-1605.
45. Pan Y, Wang C, Wang B. Phosphorylation of gli2 by protein kinase a is required for gli2 processing and degradation and the sonic hedgehog-regulated mouse development. Dev Biol 2009, 326:177-189.
46. Corbit KC, Aanstad P, Singla V, Norman AR, Stainier DY, Reiter JF. Vertebrate smoothened functions at the primary cilium. Nature 2005, 437:1018-1021.
47. Haycraft CJ, Banizs B, Aydin-Son Y, Zhang Q, Michaud EJ, Yoder BK. Gli2 and gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function. PLoS Genet 2005, 1:e53.
48. Benzing T, Schermer B. Transition zone proteins and cilia dynamics. Nat Genet 2011, 43:723-724.
49. Caspary T, Larkins CE, Anderson KV. The graded response to sonic hedgehog depends on cilia architecture. Dev Cell 2007, 12:767-778.
50. Kise Y, Takenaka K, Tezuka T, Yamamoto T, Miki H. Fused kinase is stabilized by cdc37/hsp90 and enhances gli protein levels. Biochem Biophys Res Commun 2006, 351:78-84.
51. Donnelly A, Blagg BS. Novobiocin and additional inhibitors of the hsp90 c-terminal nucleotide-binding pocket. Curr Med Chem 2008, 15:2702-2717.
52. Lachke SA, Maas RL. Building the developmental oculome: systems biology in vertebrate eye development and disease. Wiley Interdis Rev Syst Biol Med 2010, 2:305-323.
53. Vidal M, Cusick ME, Barabasi AL. Interactome networks and human disease. Cell 2011, 144:986-998.
54. Kitano H. Violations of robustness trade-offs. Mol Syst Biol 2010, 6:384.
55. Hui CC, Angers S. Gli proteins in development and disease. Ann Rev Cell Dev Biol 2011, 27:513-537.
56. Roessler E, Belloni E, Gaudenz K, Jay P, Berta P, Scherer SW, Tsui LC, Muenke M. Mutations in the human sonic hedgehog gene cause holoprosencephaly. Nat Genet 1996, 14:357-360.
57. Belloni E, Muenke M, Roessler E, Traverso G, Siegel-Bartelt J, Frumkin A, Mitchell HF, Donis-Keller H, Helms C, Hing AV, et al. Identification of sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat Genet 1996, 14:353-356.
58. Nanni L, Ming JE, Bocian M, Steinhaus K, Bianchi DW, Die-Smulders C, Giannotti A, Imaizumi K, Jones KL, Campo MD, et al. The mutational spectrum of the sonic hedgehog gene in holoprosencephaly: Shh mutations cause a significant proportion of autosomal dominant holoprosencephaly. Hum Mol Genet 1999, 8:2479-2488.
59. Roessler E, Muenke M. How a hedgehog might see holoprosencephaly. Hum Mol Genet 2003, 12 Spec 1:R15-25.
60. Schell-Apacik CC, Ertl-Wagner B, Panzel A, Klausener K, Rausch G, Muenke M, von Voss H, Hehr U. Maternally inherited heterozygous sequence change in the sonic hedgehog gene in a male patient with bilateral closed-lip schizencephaly and partial absence of the corpus callosum. Am J Med Genet A 2009, 149A:1592-1594.
61. Schimmenti LA, de la Cruz J, Lewis RA, Karkera JD, Manligas GS, Roessler E, Muenke M. Novel mutation in sonic hedgehog in non-syndromic colobomatous microphthalmia. Am J Med Genet A 2003, 116A:215-221.
62. Garavelli L, Zanacca C, Caselli G, Banchini G, Dubourg C, David V, Odent S, Gurrieri F, Neri G. Solitary median maxillary central incisor syndrome: clinical case with a novel mutation of sonic hedgehog. Am J Med Genet A 2004, 127A:93-95.
63. Bae GU, Domene S, Roessler E, Schachter K, Kang JS, Muenke M, Krauss RS. Mutations in cdon, encoding a hedgehog receptor, result in holoprosencephaly and defective interactions with other hedgehog receptors. Am J Hum Genet 2011, 89:231-240.
64. Gao B, Guo J, She C, Shu A, Yang M, Tan Z, Yang X, Guo S, Feng G, He L. Mutations in ihh, encoding Indian hedgehog, cause brachydactyly type a-1. Nat Genet 2001, 28:386-388.
65. Hellemans J, Coucke PJ, Giedion A, De Paepe A, Kramer P, Beemer F, Mortier GR. Homozygous mutations in ihh cause acrocapitofemoral dysplasia, an autosomal recessive disorder with cone-shaped epiphyses in hands and hips. Am J Hum Genet 2003, 72:1040-1046.
66. Umehara F, Tate G, Itoh K, Yamaguchi N, Douchi T, Mitsuya T, Osame M. A novel mutation of desert hedgehog in a patient with 46, xy partial gonadal dysgenesis accompanied by minifascicular neuropathy. Am J Hum Genet 2000, 67:1302-1305.
67. Canto P, Soderlund D, Reyes E, Mendez JP. Mutations in the desert hedgehog (dhh) gene in patients with 46, xy complete pure gonadal dysgenesis. J Clin Endocrinol Metab 2004, 89:4480-4483.
68. Roessler E, Du YZ, Mullor JL, Casas E, Allen WP, Gillessen-Kaesbach G, Roeder ER, Ming JE, Ruiz i Altaba A, Muenke M. Loss-of-function mutations in the human gli2 gene are associated with pituitary anomalies and holoprosencephaly-like features. Proc Natl Acad Sci U S A 2003, 100:13424-13429.
69. Rahimov F, Ribeiro LA, de Miranda E, Richieri-Costa A, Murray JC. Gli2 mutations in four Brazilian patients: How wide is the phenotypic spectrum? Am J Med Genet A 2006, 140:2571-2576.
70. Pettigrew AL, Greenberg F, Caskey CT, Ledbetter DH. Greig syndrome associated with an interstitial deletion of 7p: confirmation of the localization of greig syndrome to 7p13. Hum Genet 1991, 87:452-456.
71. Kang S, Graham JM Jr, Olney AH, Biesecker LG. Gli3 frameshift mutations cause autosomal dominant pallister-hall syndrome. Nat Genet 1997, 15:266-268.
72. Radhakrishna U, Bornholdt D, Scott HS, Patel UC, Rossier C, Engel H, Bottani A, Chandal D, Blouin JL, Solanki JV, et al. The phenotypic spectrum of gli3 morphopathies includes autosomal dominant preaxial polydactyly type-iv and postaxial polydactyly type-a/b; no phenotype prediction from the position of gli3 mutations. Am J Hum Genet 1999, 65:645-655.
73. Dagoneau N, Goulet M, Genevieve D, Sznajer Y, Martinovic J, Smithson S, Huber C, Baujat G, Flori E, Tecco L, et al. Dync2h1 mutations cause asphyxiating thoracic dystrophy and short rib-polydactyly syndrome, type iii. Am J Hum Genet 2009, 84:706-711.
74. Merrill AE, Merriman B, Farrington-Rock C, Camacho N, Sebald ET, Funari VA, Schibler MJ, Firestein MH, Cohn ZA, Priore MA, et al. Ciliary abnormalities due to defects in the retrograde transport protein dync2h1 in short-rib polydactyly syndrome. Am J Hum Genet 2009, 84:542-549.
75. Putoux A, Thomas S, Coene KL, Davis EE, Alanay Y, Ogur G, Uz E, Buzas D, Gomes C, Patrier S, et al. Kif7 mutations cause fetal hydrolethalus and acrocallosal syndromes. Nat Genet 2011, 43:601-606.
76. Dafinger C, Liebau MC, Elsayed SM, Hellenbroich Y, Boltshauser E, Korenke GC, Fabretti F, Janecke AR, Ebermann I, Nurnberg G, et al. Mutations in kif7 link joubert syndrome with sonic hedgehog signaling and microtubule dynamics. J Clin Investig 2011, 121:2662-2667.
77. Davis EE, Zhang Q, Liu Q, Diplas BH, Davey LM, Hartley J, Stoetzel C, Szymanska K, Ramaswami G, Logan CV, et al. Ttc21b contributes both causal and modifying alleles across the ciliopathy spectrum. Nat Genet 2011, 43:189-196.
78. Boehlke C, Bashkurov M, Buescher A, Krick T, John AK, Nitschke R, Walz G, Kuehn EW. Differential role of rab proteins in ciliary trafficking: Rab23 regulates smoothened levels. J Cell Sci 2010, 123:1460-1467.
79. Jenkins D, Seelow D, Jehee FS, Perlyn CA, Alonso LG, Bueno DF, Donnai D, Josifova D, Mathijssen IM, Morton JE, et al. Rab23 mutations in carpenter syndrome imply an unexpected role for hedgehog signaling in cranial-suture development and obesity. Am J Hum Genet 2007, 80:1162-1170.
80. Gilissen C, Arts HH, Hoischen A, Spruijt L, Mans DA, Arts P, van Lier B, Steehouwer M, van Reeuwijk J, Kant SG, et al. Exome sequencing identifies wdr35 variants involved in sensenbrenner syndrome. Am J Hum Genet 2010, 87:418-423.
81. Mill P, Lockhart PJ, Fitzpatrick E, Mountford HS, Hall EA, Reijns MA, Keighren M, Bahlo M, Bromhead CJ, Budd P, et al. Human and mouse mutations in wdr35 cause short-rib polydactyly syndromes due to abnormal ciliogenesis. Am J Hum Genet 2011, 88:508-515.
82. Cantagrel V, Silhavy JL, Bielas SL, Swistun D, Marsh SE, Bertrand JY, Audollent S, Attie-Bitach T, Holden KR, Dobyns WB, et al. Mutations in the cilia gene arl13b lead to the classical form of joubert syndrome. Am J Hum Genet 2008, 83:170-179.
83. Garcia-Gonzalo FR, Corbit KC, Sirerol-Piquer MS, Ramaswami G, Otto EA, Noriega TR, Seol AD, Robinson JF, Bennett CL, Josifova DJ, et al. A transition zone complex regulates mammalian ciliogenesis and ciliary membrane composition. Nat Genet 2011, 43:776-784.
84. Shaheen R, Faqeih E, Seidahmed MZ, Sunker A, Alali FE, AlQahtani K, Alkuraya FS. A tctn2 mutation defines a novel meckel gruber syndrome locus. Hum Mutat 2011, 32:573-578.
85. Vorechovsky I, Tingby O, Hartman M, Stromberg B, Nister M, Collins VP, Toftgard R. Somatic mutations in the human homologue of drosophila patched in primitive neuroectodermal tumours. Oncogene 1997, 15:361-366.
86. Wolter M, Reifenberger J, Sommer C, Ruzicka T, Reifenberger G. Mutations in the human homologue of the drosophila segment polarity gene patched (ptch) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1997, 57:2581-2585.
87. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Jr, Scott MP. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996, 272:1668-1671.
88. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, et al. Mutations of the human homolog of drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996, 85:841-851.
89. Gailani MR, Stahle-Backdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, Unden AB, Dean M, Brash DE, Bale AE, et al. The role of the human homologue of drosophila patched in sporadic basal cell carcinomas. Nat Genet 1996, 14:78-81.
90. Aszterbaum M, Rothman A, Johnson RL, Fisher M, Xie J, Bonifas JM, Zhang X, Scott MP, Epstein EH, Jr. Identification of mutations in the human patched gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol 1998, 110:885-888.
91. Xie J, Johnson RL, Zhang X, Bare JW, Waldman FM, Cogen PH, Menon AG, Warren RS, Chen LC, Scott MP, et al. Mutations of the patched gene in several types of sporadic extracutaneous tumors. Cancer Res 1997, 57:2369-2372.
92. Smyth I, Narang MA, Evans T, Heimann C, Nakamura Y, Chenevix-Trench G, Pietsch T, Wicking C, Wainwright BJ. Isolation and characterization of human patched 2 (ptch2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32. Hum Mol Genet 1999, 8:291-297.
93. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard A, et al. Activating smoothened mutations in sporadic basal-cell carcinoma. Nature 1998, 391:90-92.
94. Lam CW, Xie J, To KF, Ng HK, Lee KC, Yuen NW, Lim PL, Chan LY, Tong SF, McCormick F. A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene 1999, 18:833-836.
95. Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, Zhang X, Agatep R, Chiappa S, Gao L, Lowrance A, et al. Mutations in sufu predispose to medulloblastoma. Nat Genet 2002, 31:306-310.
96. Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G. Somatic mutations in the ptch, smoh, sufuh and tp53 genes in sporadic basal cell carcinomas. Br J Dermatol 2005, 152:43-51.
97. de Bont JM, Packer RJ, Michiels EM, den Boer ML, Pieters R. Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective. Neuro-oncol 2008, 10:1040-1060.
98. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. Truncating mutations of hsnf5/ini1 in aggressive paediatric cancer. Nature 1998, 394:203-206.
99. Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P. Germline mutation of ini1/smarcb1 in familial schwannomatosis. Am J Hum Genet 2007, 80:805-810.
100. Wang GY, Wang J, Mancianti ML, Epstein EH, Jr. Basal cell carcinomas arise from hair follicle stem cells in ptch1(+/-) mice. Cancer cell 2011, 19:114-124.
101. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003, 422:313-317.
102. Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Isaacs JT, Berman DM, Beachy PA. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004, 431:707-712.
103. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, et al. Widespread requirement for hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003, 425:846-851.
104. Han YG, Kim HJ, Dlugosz AA, Ellison DW, Gilbertson RJ, Alvarez-Buylla A. Dual and opposing roles of primary cilia in medulloblastoma development. Nature Med 2009, 15:1062-1065.
105. Wong SY, Seol AD, So PL, Ermilov AN, Bichakjian CK, Epstein EH Jr, Dlugosz AA, Reiter JF. Primary cilia can both mediate and suppress hedgehog pathway-dependent tumorigenesis. Nature Med 2009, 15:1055-1061.
106. Ericson J, Morton S, Kawakami A, Roelink H, Jessell TM. Two critical periods of sonic hedgehog signaling required for the specification of motor neuron identity. Cell 1996, 87:661-673.
107. Keeler RF, Binns W. Teratogenic compounds of veratrum californicum (durand). V. Comparison of cyclopian effects of steroidal alkaloids from the plant and structurally related compounds from other sources. Teratology 1968, 1:5-10.
108. Romer JT, Kimura H, Magdaleno S, Sasai K, Fuller C, Baines H, Connelly M, Stewart CF, Gould S, Rubin LL, et al. Suppression of the shh pathway using a small molecule inhibitor eliminates medulloblastoma in ptc1(+/-)p53(-/-) mice. Cancer Cell 2004, 6:229-240.
109. Pan SF, Wu X, Jiang JQ, Gao WQ, Wan YQ, Cheng D, Han D, Liu J, Englund NP, Wang Y, et al. Discovery of nvp-lde225, a potent and selective smoothened antagonist. ACS Med Chem Lett 2010, 1:130-134.
110. Rohner A, Spilker ME, Lam JL, Pascual B, Bartkowski D, Li QJ, Yang AH, Stevens G, Xu M, Wells PA, et al. Effective targeting of hedgehog signaling in a medulloblastoma model with pf-5274857, a potent and selective smoothened antagonist that penetrates the blood-brain barrier. Mol Cancer Therap 2012, 11:57-65.
111. Ferruzzi P, Mennillo F, De Rosa A, Giordano C, Rossi M, Benedetti G, Magrini R, Mohr GL, Miragliotta V, Magnoni L, et al. In vitro and in vivo characterization of a novel hedgehog signaling antagonist in human glioblastoma cell lines. Int J Cancer 2011, 131:E33-E44.
112. Malancona S, Altamura S, Filocamo G, Kinzel O, Hernando JI, Rowley M, Scarpelli R, Steinkuhler C, Jones P. Identification of mk-5710 ((8as)-8a-methyl-1, 3-dioxo-2-[(1s, 2r)-2-phenylcyclopropyl]-n-(1-phenyl-1h-pyrazol-5-yl)hexahydroimid azo[1, 5-a]pyrazine-7(1h)-carboxamide), a potent smoothened antagonist for use in hedgehog pathway dependent malignancies, part 1. Bioorg Med Chem Lett 2011, 21:4422-4428.
113. Kinzel O, Alfieri A, Altamura S, Brunetti M, Bufali S, Colaceci F, Ferrigno F, Filocamo G, Fonsi M, Gallinari P, et al. Identification of mk-5710 ((8as)-8a-methyl-1, 3-dioxo-2-[(1s, 2r)-2-phenylcyclo- propyl]-n-(1-phenyl-1h-pyrazol-5-yl)hexahydro-imidazo[1, 5-a]pyrazine-7(1h)-carbox amide), a potent smoothened antagonist for use in hedgehog pathway dependent malignancies, part 2. Bioorg Med Chem Lett 2011, 21:4429-4435.
114. Strand MF, Wilson SR, Dembinski JL, Holsworth DD, Khvat A, Okun I, Petersen D, Krauss S. A novel synthetic smoothened antagonist transiently inhibits pancreatic adenocarcinoma xenografts in a mouse model. PLoS One 2011, 6:e19904.
115. Guerlet G, Spangenberg T, Mann A, Faure H, Ruat M. Synthesis and biological evaluation of desmethylveramiline, a micromolar hedgehog inhibitor. Bioorg Med Chem Lett 2011, 21:3608-3612.
116. Roudaut H, Traiffort E, Gorojankina T, Vincent L, Faure H, Schoenfelder A, Mann A, Manetti F, Solinas A, Taddei M, et al. Identification and mechanism of action of the acylguanidine mrt-83, a novel potent smoothened antagonist. Mol Pharmacol 2011, 79:453-460.
117. Chen JK, Taipale J, Young KE, Maiti T, Beachy PA. Small molecule modulation of smoothened activity. Proc Natl Acad Sci U S A 2002, 99:14071-14076.
118. Manetti F, Faure H, Roudaut H, Gorojankina T, Traiffort E, Schoenfelder A, Mann A, Solinas A, Taddei M, Ruat M. Virtual screening-based discovery and mechanistic characterization of the acylthiourea mrt-10 family as smoothened antagonists. Mol Pharmacol 2010, 78:658-665.
119. Tremblay MR, Lescarbeau A, Grogan MJ, Tan E, Lin G, Austad BC, Yu LC, Behnke ML, Nair SJ, Hagel M, et al. Discovery of a potent and orally active hedgehog pathway antagonist (ipi-926). J Med Chem 2009, 52:4400-4418.
120. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, et al. Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009, 324:1457-1461.
121. Yang H, Xiang J, Wang N, Zhao Y, Hyman J, Li S, Jiang J, Chen JK, Yang Z, Lin S. Converse conformational control of smoothened activity by structurally related small molecules. J Biol Chem 2009, 284:20876-20884.
122. Feldmann G, Fendrich V, McGovern K, Bedja D, Bisht S, Alvarez H, Koorstra JB, Habbe N, Karikari C, Mullendore M, et al. An orally bioavailable small-molecule inhibitor of hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer. Mol Cancer therap 2008, 7:2725-2735.
123. Frank-Kamenetsky M, Zhang XM, Bottega S, Guicherit O, Wichterle H, Dudek H, Bumcrot D, Wang FY, Jones S, Shulok J, et al. Small-molecule modulators of hedgehog signaling: Identification and characterization of smoothened agonists and antagonists. J Biol 2002, 1:10.
124. Kim J, Tang JY, Gong R, Kim J, Lee JJ, Clemons KV, Chong CR, Chang KS, Fereshteh M, Gardner D, et al. Itraconazole, a commonly used antifungal that inhibits hedgehog pathway activity and cancer growth. Cancer Cell 2010, 17:388-399.
125. Lauth M, Bergstrom A, Shimokawa T, Toftgard R. Inhibition of gli-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci U S A 2007, 104:8455-8460.
126. Hyman JM, Firestone AJ, Heine VM, Zhao Y, Ocasio CA, Han K, Sun M, Rack PG, Sinha S, Wu JJ, et al. Small-molecule inhibitors reveal multiple strategies for hedgehog pathway blockade. Proc Natl Acad Sci U S A 2009, 106:14132-14137.
127. Hosoya T, Arai MA, Koyano T, Kowithayakorn T, Ishibashi M. Naturally occurring small-molecule inhibitors of hedgehog/gli-mediated transcription. Chembiochem 2008, 9:1082-1092.
128. Slusarz A, Shenouda NS, Sakla MS, Drenkhahn SK, Narula AS, MacDonald RS, Besch-Williford CL, Lubahn DB. Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Res 2010, 70:3382-3390.
129. Corcoran RB, Scott MP. Oxysterols stimulate sonic hedgehog signal transduction and proliferation of medulloblastoma cells. Proc Natl Acad Sci U S A 2006, 103:8408-8413.
130. Sinha S, Chen JK. Purmorphamine activates the hedgehog pathway by targeting smoothened. Nat Chem Biol 2006, 2:29-30.
131. Ng JM, Curran T. The hedgehog's tale: developing strategies for targeting cancer. Nature Rev Cancer 2011, 11:493-501.
132. Hassounah NB, Bunch TA, McDermott KM. Molecular pathways: the role of primary cilia in cancer progression and therapeutics with a focus on hedgehog signaling. Clin Cancer Res 2012, 18:2429-2435.
133. Kitano H. Cancer as a robust system: implications for anticancer therapy. Nat Rev Cancer 2004, 4:227-235.
134. Kim J, Dabiri S, Seeley ES. Primary cilium depletion typifies cutaneous melanoma in situ and malignant melanoma. PLoS One 2011, 6:e27410.
135. Yuan K, Frolova N, Xie Y, Wang D, Cook L, Kwon YJ, Steg AD, Serra R, Frost AR. Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues. J Histochem Cytochem 2010, 58:857-870.
136. Seeley ES, Carriere C, Goetze T, Longnecker DS, Korc M. Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia. Cancer Res 2009, 69:422-430.
137. Farzan SF, Stegman MA, Ogden SK, Ascano M Jr, Black KE, Tacchelly O, Robbins DJ. A quantification of pathway components supports a novel model of hedgehog signal transduction. J Biol Chem 2009, 284:28874-28884.
138. Nahmad M, Stathopoulos A. Dynamic interpretation of hedgehog signaling in the drosophila wing disc. PLoS Biol 2009, 7:e1000202.
139. Parker DS, White MA, Ramos AI, Cohen BA, Barolo S. The cis-regulatory logic of hedgehog gradient responses: key roles for gli binding affinity, competition, and cooperativity. Sci Signal 2011, 4:ra38.
140. Schilling S, Willecke M, Aegerter-Wilmsen T, Cirpka OA, Basler K, von Mering C. Cell-sorting at the a/p boundary in the drosophila wing primordium: a computational model to consolidate observed non-local effects of hh signaling. PLoS Comput Biol 2011, 7:e1002025.
141. Huang BMT, LaRusso N. Isolation of primary cilia for morphological analysis. Methods Cell Biol 2009, 93:103-115.
142. Ishikawa H, Thompson J, Yates JR 3rd, Marshall WF. Proteomic analysis of mammalian primary cilia. Curr Biol 2012, 22:414-419.
143. Nishi Y, Ji H, Wong WH, McMahon AP, Vokes SA. Modeling the spatio-temporal network that drives patterning in the vertebrate central nervous system. Biochim Biophys Acta 2009, 1789:299-305.
144. Vokes SA, Ji H, Wong WH, McMahon AP. A genome-scale analysis of the cis-regulatory circuitry underlying sonic hedgehog-mediated patterning of the mammalian limb. Genes Dev 2008, 22:2651-2663.
145. Lee EY, Ji H, Ouyang Z, Zhou B, Ma W, Vokes SA, McMahon AP, Wong WH, Scott MP. Hedgehog pathway-regulated gene networks in cerebellum development and tumorigenesis. Proc Natl Acad Sci U S A 2010, 107:9736-9741.
146. Jin Y, Ratnam K, Chuang PY, Fan Y, Zhong Y, Dai Y, Mazloom AR, Chen EY, D'Agati V, Xiong H, et al. A systems approach identifies hipk2 as a key regulator of kidney fibrosis. Nat Med 2012, 18:580-588.